Literature DB >> 2989733

Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.

S J Bunn, M R Hanley, G P Wilkin.   

Abstract

Specific binding of the opioid ligand [3H]etorphine was localized in cryostat sections of the rat pituitary. The binding was concentrated over the pars nervosa. Competition with partially selective unlabelled displacers indicated that the greater part of this binding was of the kappa-subtype, sensitive to inhibition by dynorphin and bremazocine. The kappa nature of the binding was confirmed using the prototype kappa ligand [3H]ethylketocyclazocine in the presence of excess unlabelled mu and delta opioid receptor ligands. Sections of the pituitary stalk caused a loss of the hypothalamic projection to the pars nervosa and a marked gliosis. Concurrent with these changes there was a significant increase in the density of kappa opioid binding. These observations suggest that the majority of opioid receptors in the pars nervosa are of the kappa subtype and are located on the pituicytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989733     DOI: 10.1016/0304-3940(85)90455-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

Review 1.  Toll-like receptors in chronic pain.

Authors:  Lauren Nicotra; Lisa C Loram; Linda R Watkins; Mark R Hutchinson
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.

Authors:  C A Bondy; M H Whitnall; L S Brady; H Gainer
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

4.  Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes.

Authors:  K F Hauser; J G Osborne; A Stiene-Martin; M H Melner
Journal:  Brain Res       Date:  1990-07-09       Impact factor: 3.252

7.  kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover.

Authors:  J Barg; M M Belcheva; J Rowiński; C J Coscia
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

8.  Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.

Authors:  G Dayanithi; E L Stuenkel; J J Nordmann
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

9.  Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.

Authors:  Mei Xu; Michael Petraschka; Jay P McLaughlin; Ruth E Westenbroek; Marc G Caron; Robert J Lefkowitz; Traci A Czyzyk; John E Pintar; Gregory W Terman; Charles Chavkin
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

Review 10.  Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.

Authors:  Bradley Nash; Olimpia Meucci
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.